These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 17266545)
1. The role of the thrombospondins in healing myocardial infarcts. Chatila K; Ren G; Xia Y; Huebener P; Bujak M; Frangogiannis NG Cardiovasc Hematol Agents Med Chem; 2007 Jan; 5(1):21-7. PubMed ID: 17266545 [TBL] [Abstract][Full Text] [Related]
2. Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts. Frangogiannis NG; Ren G; Dewald O; Zymek P; Haudek S; Koerting A; Winkelmann K; Michael LH; Lawler J; Entman ML Circulation; 2005 Jun; 111(22):2935-42. PubMed ID: 15927970 [TBL] [Abstract][Full Text] [Related]
4. Thrombospondin-1 induction in the diabetic myocardium stabilizes the cardiac matrix in addition to promoting vascular rarefaction through angiopoietin-2 upregulation. Gonzalez-Quesada C; Cavalera M; Biernacka A; Kong P; Lee DW; Saxena A; Frunza O; Dobaczewski M; Shinde A; Frangogiannis NG Circ Res; 2013 Dec; 113(12):1331-44. PubMed ID: 24081879 [TBL] [Abstract][Full Text] [Related]
6. Endogenous thrombospondin 1 protects the pressure-overloaded myocardium by modulating fibroblast phenotype and matrix metabolism. Xia Y; Dobaczewski M; Gonzalez-Quesada C; Chen W; Biernacka A; Li N; Lee DW; Frangogiannis NG Hypertension; 2011 Nov; 58(5):902-11. PubMed ID: 21947471 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-10 is not a critical regulator of infarct healing and left ventricular remodeling. Zymek P; Nah DY; Bujak M; Ren G; Koerting A; Leucker T; Huebener P; Taffet G; Entman M; Frangogiannis NG Cardiovasc Res; 2007 May; 74(2):313-22. PubMed ID: 17188669 [TBL] [Abstract][Full Text] [Related]
8. Thrombospondin in renal disease. Hugo C; Daniel C Nephron Exp Nephrol; 2009; 111(3):e61-6. PubMed ID: 19182492 [TBL] [Abstract][Full Text] [Related]
9. Thrombospondin-2 therapy ameliorates experimental glomerulonephritis via inhibition of cell proliferation, inflammation, and TGF-beta activation. Daniel C; Wagner A; Hohenstein B; Hugo C Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1299-309. PubMed ID: 19726547 [TBL] [Abstract][Full Text] [Related]
10. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Bujak M; Frangogiannis NG Cardiovasc Res; 2007 May; 74(2):184-95. PubMed ID: 17109837 [TBL] [Abstract][Full Text] [Related]
11. Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction. Bujak M; Kweon HJ; Chatila K; Li N; Taffet G; Frangogiannis NG J Am Coll Cardiol; 2008 Apr; 51(14):1384-92. PubMed ID: 18387441 [TBL] [Abstract][Full Text] [Related]